Scientists have launched the first human trials of a drug designed to target one of cancer’s most elusive drivers. The treatment focuses on a gene mutation long considered “undruggable” by conventional medicine. This gene plays a role in the development of roughly 70% of all cancers, influencing how tumors grow, survive, and resist treatment. Successfully targeting it could have wide-reaching implications across many cancer types. The new drug works by disrupting the molecular pathways cancer ce